ANPEP and neoplasm: This fact makes APN/CD13 an interesting and specific receptor for so-called “tumor-homing peptides” (NRG peptides), which bind to APN with high affinity, and thus represent a promising target for the inhibition of tumor-induced angiogenesis as well as for the tumor-selective administration of, e.g., cytotoxic substances [156,157,158].